Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

First-half 2013 turnover



Clermont-Ferrand, 18 July 2013 – METabolic EXplorer, a green chemistry company that specializes in the development of bioprocesses for the production of chemical compounds used in a wide range of everyday products (textile fibres, paints, solvents, animal feed supplements, adhesives, etc.), today published its financial data for the second quarter of 2013.


Turnover for second quarter 2013 was €375,000. This resulted from the partnership with the Roquette group, for the industrial development of L-Methionine.


 





























Turnover (IFRS) – in €'000 2012 2013
1st quarter 1350 0
2nd quarter 750 375
First-half turnover 2100 375
Annual turnover 2100  

 


At this stage of METabolic EXplorer's development, this turnover figure is in no way a relevant metric of its value or business.


As of June 30th, 2013, METabolic EXplorer had cash and equivalent of €20.6 million compared with €23.2 million as of December 31st, 2012.


 


-ENDS-


 


About METabolic EXplorer - www.metabolic-explorer.com

METabolic EXplorer is a biological chemistry company which was incorporated in 1999. Its goal is to help industrial businesses deal with the rise in oil prices, so that they can continue to manufacture but in a sustainable way.


Based on the tried and tested principle of industrial fermentation, METabolic Explorer's solutions replace today's petrochemical processes with the use of a wide range of plant-based raw materials. By optimizing the metabolic yield of non-pathogenic bacteria in a contained, controlled environment, the company facilitates the production of chemical compounds used in a wide range of everyday goods (textile fibres, paints, solvents, plastics and animal feed).


METabolic EXplorer is currently focusing its alternative processes on the production of three compounds that together have an estimated, annual, end-market value of €7 billion. The company's strategy will be implemented in forms such as own-account developments (ie, manufacturing plants) in geographically strategic regions and via industrial partnerships in the shape of joint ventures and licences.


METabolic EXplorer, based in Clermont-Ferrand, France, is listed on EURONEXT PARIS (EURONEXT C, METEX) and features in CAC Small.


 


Get free financial information on METabolic EXplorer by registering with

www.metabolic-explorer.com or www.actus-finance.com.


 


METabolic EXplorer contacts

Media and shareholder contacts

ATTITUDE Corporate


Eric de Lambert

E-mail: [email protected]

Tel.: +33 (0)1 4970 4341 / +33 (0)6 2529 0658

 


 


Investor and analyst contacts

Actus Finance & Communication


Jérôme Fabreguettes-Leib

E-mail: [email protected]

Tel.: +33 (0)1 7735 0436

 


This communication includes forward-looking information which is subject to risks and uncertainties. The potential development of the company could be substantially different from that anticipated in this press release because of the various risk factors which are described in the company's Listing Prospectus.


Information réglementée
Communiqués au titre de l'obligation d'information permanente :

- Communiqué sur comptes, résultats, chiffres d'affaires

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-32828-metex-12-pr-t2-2013-tunover-18-07-13.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Metabolic Explorer Aktie

0,095 €
-11,55 %
Die Metabolic Explorer Aktie erlebt heute einen großen Rückgang, um -11,55 %.

Like: 0
Teilen

Kommentare